Vanda Pharmaceuticals Inc. - Common Stock —— 季度现金流量表 (NASDAQ:VNDA) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 656.2 M631.94 M624.75 M601.14 M488.95 M433.52 M 负债总额 117.66 M120.52 M138.42 M135.14 M161.76 M152.76 M 权益总额 538.55 M511.42 M486.33 M466 M327.19 M280.76 M 负债及股东权益总额 656.2 M631.94 M624.75 M601.14 M488.95 M433.52 M 总债务 —————— 净债务 ——————

新闻

Vanda: A Long-Term Pharma Growth Idea, Despite Q1 Earnings Miss (NASDAQ:VNDA)

Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates

Wall Street Analysts Predict a 105.03% Upside in Vanda (VNDA): Here's What You Should Know

Incyte (INCY) Beats Q1 Earnings and Revenue Estimates

AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB)

Four Biotech Stocks Near Buy Points As Earnings Season Kicks In

Vanda制药在公民人寿科学会议上展望战略增长

Vanda Pharmaceuticals at The Citizens Life Sciences Conference: Strategic Growth Insights

Micron and Palantir among market cap stock movers on Tuesday

Truist首次覆盖Vanda Pharmaceuticals股票,基于药物管线给予买入评级

Truist initiates Vanda Pharmaceuticals stock at buy on drug pipeline

FDA批准Vanda就Hetlioz时差适应症申请举行听证会